Efficiency of Combined Hepatoprotector Forceliv in the Treatment of Chronic Diffuse Liver Disease

The article presents the results of a study of serum alanine aminotransferase levels in patients with chronic diffuse liver diseases on the background of combined hepatoprotector Forceliv application. According to the findings, a significant decrease of this indicator in all examined patients has be...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yu.M. Stepanov, Yu.S. Breslavets, I.Yu. Zavyalova, S.V. Kosynska, V.B. Yagmur, N.G. Zaichenko, V.M. Gladun, D.V. Popok, M.L. Pleschenko, S.L. Melanych, O.V. Mosyntseva, I.I. Slakva, L.V. Borodina, V.Yu Poleshko, J.V. Stepanova
Formato:	Artigo
Idioma:	Inglês
Publicado:	Zaslavsky O.Yu. 2014-11-01
Series:	Gastroenterologìa
Assuntos:	chronic diffuse liver disease alanine aminotransferase hepatoprotector Forceliv
Acceso en liña:	http://gastro.zaslavsky.com.ua/article/view/82048
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!